Lymphoma on Rheumatology Digesthttps://rheumatologydigest.org/tags/lymphoma/Recent content in Lymphoma on Rheumatology DigestHugoen-usMon, 13 Jul 2026 05:00:00 +0530Sjögren Disease — B Cells, Lymphomagenesis and Novel B-Cell Therapieshttps://rheumatologydigest.org/posts/sjogrens-b-cells-lymphoma-therapies/Mon, 13 Jul 2026 05:00:00 +0530https://rheumatologydigest.org/posts/sjogrens-b-cells-lymphoma-therapies/A 2026 narrative review arguing that B cells are the single through-line of Sjögren disease — connecting autoantibodies, glandular pathology, the highest lymphoma risk of any autoimmune disease, and the emerging drug pipeline. Endotyping by B-cell activity may identify who develops lymphoma and who responds to B-cell-targeted therapy, as newer BAFF/APRIL, CD40L, BTK and FcRn agents succeed where rituximab failed.